Q2 2025 |
30 |
$1.65B |
+$535M |
-$213M |
+$323M |
NXE, HBM, EGO, AA, EQX
|
Restatement |
9/11/2025, 11:38 AM |
Q1 2025 |
14 |
$1.07B |
+$284M |
-$47.2M |
+$237M |
EGO, NXE, CVE, FLUT, HBM
|
13F-HR |
5/15/2025, 04:58 PM |
Q4 2024 |
14 |
$570M |
$0 |
$0 |
|
EGO, RYAAY, CVE, CRH, GPK
|
13F-HR |
2/14/2025, 04:09 PM |
Q3 2024 |
11 |
$583M |
$0 |
$0 |
|
CRH, CVE, RYAAY, EGO, FLUT
|
13F-HR |
11/14/2024, 04:52 PM |
Q2 2024 |
8 |
$380M |
$0 |
$0 |
|
CVE, CRH, DELL
|
13F-HR |
8/14/2024, 04:12 PM |
Q1 2024 |
7 |
$729M |
+$266M |
-$313M |
-$47.9M |
CVE, TECK, CRH, TSM, AA
|
13F-HR |
5/15/2024, 04:09 PM |
Q4 2023 |
9 |
$701M |
+$83.1M |
-$298M |
-$215M |
CRH, CVE, TECK, HCC, GPK
|
13F-HR |
2/14/2024, 04:16 PM |
Q3 2023 |
13 |
$889M |
+$253M |
-$54.8M |
+$198M |
CVE, CRH, TECK, BABA, KWEB
|
13F-HR |
11/14/2023, 04:11 PM |
Q2 2023 |
14 |
$637M |
+$213M |
-$149M |
+$63.5M |
TECK, CVE, BABA, KWEB, HCC
|
13F-HR |
8/14/2023, 05:08 PM |
Q1 2023 |
9 |
$576M |
+$299M |
-$63.7M |
+$235M |
TECK, CVE, HCC, GPK, SCO
|
13F-HR |
5/15/2023, 04:24 PM |
Q4 2022 |
10 |
$529M |
+$256M |
-$98.8M |
+$157M |
UCO, BABA, BP, TECK, KWEB
|
13F-HR |
2/14/2023, 03:13 PM |
Q3 2022 |
8 |
$365M |
|
|
|
CVE, TECK, BABA, GPK, HCC
|
13F-HR |
11/14/2022, 03:22 PM |
Q2 2022 |
7 |
$283M |
|
|
|
CVE, TECK, AA, GPK, FERG
|
13F-HR |
8/15/2022, 05:02 PM |
Q1 2022 |
9 |
$496M |
+$154M |
-$21.9M |
+$132M |
HBM, TRQ, NXE, GPK, FXLV
|
13F-HR |
5/16/2022, 04:17 PM |
Q4 2021 |
10 |
$482M |
+$101M |
-$18.7M |
+$82.8M |
BABA, GDS, FXLV, GPK, AA
|
13F-HR |
2/14/2022, 03:10 PM |
Q3 2021 |
15 |
$804M |
+$408M |
-$104M |
+$304M |
CVE, FXLV, TECK, BABA, HBM
|
13F-HR |
11/15/2021, 04:22 PM |
Q2 2021 |
10 |
$484M |
+$148M |
-$119M |
+$29.1M |
CVE, TECK, HBM, CNQ, NXE
|
13F-HR |
8/16/2021, 04:24 PM |
Q1 2021 |
11 |
$398M |
+$33.5M |
-$218M |
-$185M |
TECK, CVE, WFC, CNQ, PANW
|
13F-HR |
5/7/2021, 07:16 AM |
Q4 2020 |
15 |
$536M |
+$236M |
-$13.6M |
+$223M |
TECK, LYFT, CVE, WFC, BBBYQ
|
13F-HR |
2/16/2021, 01:06 PM |
Q3 2020 |
11 |
$196M |
+$80.8M |
-$6.53M |
+$74.3M |
BBBYQ, ESRT, HCC, ARWR, MDGL
|
13F-HR |
11/13/2020, 03:02 PM |
Q2 2020 |
14 |
$293M |
|
|
|
TECK, HCC, ESRT, CHTR, CVE
|
13F-HR |
8/14/2020, 11:06 AM |